enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Mirvetuximab soravtansine - Wikipedia

    en.wikipedia.org/wiki/Mirvetuximab_soravtansine

    Mirvetuximab soravtansine, sold under the brand name Elahere, is a medication used as a treatment for epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. [ 2 ] [ 5 ] Mirvetuximab soravtansine is a folate receptor alpha directed antibody and microtubule inhibitor conjugate.

  3. Cantuzumab ravtansine - Wikipedia

    en.wikipedia.org/wiki/Cantuzumab_ravtansine

    This page was last edited on 8 December 2023, at 11:54 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.

  4. ImmunoGen - Wikipedia

    en.wikipedia.org/wiki/ImmunoGen

    ImmunoGen, Inc. was a biotechnology company focused on the development of antibody-drug conjugate (ADC) therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and was headquartered in Waltham, Massachusetts.

  5. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    Therapeutic, diagnostic and preventive monoclonal antibodies are clones of a single parent cell. When used as drugs, the International Nonproprietary Names (INNs) end in -mab.

  6. Indatuximab ravtansine - Wikipedia

    en.wikipedia.org/wiki/Indatuximab_ravtansine

    CD138 is highly overexpressed on various solid tumors and in hematological malignancies, and represents one of the most specific target antigens for identification of multiple myeloma (MM) cells. [1]

  7. File:Mirvetuximab soravtansine.svg - Wikipedia

    en.wikipedia.org/wiki/File:Mirvetuximab...

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file

  8. Maitansine - Wikipedia

    en.wikipedia.org/wiki/Maitansine

    Derivatives of maitansine are known as maytansinoids. [3] [4] Some are being investigated as the cytotoxic component of antibody-drug conjugates for cancer treatment, [5] and the antibody-drug conjugate trastuzumab emtansine is an approved drug for the treatment of certain kinds of breast cancer in the EU and in the US.

  9. Bivatuzumab mertansine - Wikipedia

    en.wikipedia.org/wiki/Bivatuzumab_mertansine

    This page was last edited on 5 February 2023, at 17:24 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.